Publications by authors named "Kah Weng Lau"

Article Synopsis
  • AI solutions for Gleason grading show potential for pathologists, but face challenges like inconsistent image quality and limited adaptability to different data sources.
  • The proposed digital pathology workflow includes AI-driven components for image quality control, cloud annotation, and ongoing model improvements, achieving promising results across various scanner types.
  • The model notably improves Gleason scoring speed by 43% and enhances accuracy, making it a significant step towards integrating AI in clinical practices for better diagnostic consistency.
View Article and Find Full Text PDF

Cancer cells undergo transcriptional reprogramming to drive tumor progression and metastasis. Using cancer cell lines and patient-derived tumor organoids, we demonstrate that loss of the negative elongation factor (NELF) complex inhibits breast cancer development through downregulating epithelial-mesenchymal transition (EMT) and stemness-associated genes. Quantitative multiplexed Rapid Immunoprecipitation Mass spectrometry of Endogenous proteins (qPLEX-RIME) further reveals a significant rewiring of NELF-E-associated chromatin partners as a function of EMT and a co-option of NELF-E with the key EMT transcription factor SLUG.

View Article and Find Full Text PDF

Introduction: Programmed cell death protein-1 (PD-1) and programmed death-ligand 1 (PD-L1) blockade is currently widely used in the treatment of metastatic NSCLC. Despite available biomarker stratification, clinical responses vary. Thus, the search for novel biomarkers with improved response prediction is ongoing.

View Article and Find Full Text PDF

The advent of targeted therapies has established new standards of care for defined molecular subsets of non-small cell lung cancer (NSCLC). Not only has this led to significant changes in the routine clinical management of lung cancer e.g.

View Article and Find Full Text PDF

Background: We describe an unusual case of 2 intra-parenchymal breast melanomas with a concomitant subcutaneous melanoma in the ipsilateral upper limb and no definite primary lesion.

Case Report: Our patient is a 40-year-old Chinese female who presented with a breast lump in her left breast for which excision biopsy showed melanoma. A PET-CT revealed a second lesion in her breast.

View Article and Find Full Text PDF

Papillary tumors of the peripheral lung containing ciliated cells and extracellular mucin include solitary peripheral ciliated glandular papilloma, ciliated muconodular papillary tumor, and well-differentiated papillary adenocarcinoma with cilia formation. We report the case of a 19-year-old woman who was a nonsmoker and presented with an incidental small peripheral lung nodule. The resection specimen showed a soft grayish nodule.

View Article and Find Full Text PDF

Background: Inactivation of the Von Hippel-Lindau (VHL) tumour suppressor gene leading to overexpression of hypoxia-inducible transcription factors (HIF)-1alpha and -2alpha is a critical event in the pathogenesis of most clear cell renal cell carcinomas (RCC). HIF-1alpha and HIF-2alpha share significant homology and regulate overlapping repertoires of hypoxia-inducible target genes but may have differing effects on RCC cell growth. Loss of HIF-1alpha expression has been described in RCC cell lines and primary tumours.

View Article and Find Full Text PDF

Defective function of the von Hippel-Lindau (VHL) tumor suppressor ablates proteolytic regulation of hypoxia-inducible factor alpha subunits (HIF-1alpha and HIF-2alpha), leading to constitutive activation of hypoxia pathways in renal cell carcinoma (RCC). Here we report a comparative analysis of the functions of HIF-1alpha and HIF-2alpha in RCC and non-RCC cells. We demonstrate common patterns of HIF-alpha isoform transcriptional selectivity in VHL-defective RCC that show consistent and striking differences from patterns in other cell types.

View Article and Find Full Text PDF
Article Synopsis
  • The von Hippel-Lindau (VHL) tumor suppressor acts as a ubiquitin ligase, targeting hydroxylated alpha subunits of hypoxia-inducible factor (HIF) for degradation, impacting tumor growth.
  • Research on VHL-deficient renal cancer cells hints at additional pathways beyond HIF, but separating these effects from HIF-related issues is challenging.
  • A genetic study in Caenorhabditis elegans revealed that, besides its role in the HIF pathway, VHL-1 also regulates genes linked to extracellular matrix function, demonstrating HIF-independent effects.
View Article and Find Full Text PDF